Answers are grounded in this paper and cite their sources.
Article1 November 1956TREATMENT OF MULTIPLE SCLEROSIS WITH LOW-FAT DIET: RESULT OF SEVEN YEARS' EXPERIENCEROY L. SWANK, M.D.ROY L. SWANK, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-45-5-812 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptExperimental therapy of chronic diseases demands patience and persistence if a definite conclusion is to be reached. The period of therapy must bear some relationship to the normally expected duration of the disease. Multiple sclerosis is thought to have an average duration of 20 to 25 years. The same person or persons should evaluate the patients periodically from the beginning to the end of the study. It hardly need be added that the same patients must be followed continuously during the entire period of treatment.It is not necessary, but would probably be helpful, that the progress of the study...Bibliography1. Swank RL: Treatment of multiple sclerosis with low-fat diet, Arch. Neurol. and Psychiat. 69: 91, 1953. CrossrefGoogle Scholar2. Swank RL: Treatment of multiple sclerosis with low-fat diet, Arch. Neurol. and Psychiat. 73: 631, 1955. CrossrefGoogle Scholar3. Ackerman A: Die multiple Sklerose in der Schweiz, Schweiz. med. Wchnschr. 61: 1245, 1931. Google Scholar4. Gram HC: Occurrence of disseminated sclerosis in Denmark, Ugesk. f. læger 96: 823, 1934. Google Scholar5. Limburg CC: Geographic distribution of multiple sclerosis and its estimated prevalence in the United States, A. Research Nerv. and Ment. Dis., Proc. (1948) 28: 15, 1950. MedlineGoogle Scholar6. WestlundKurland KBLT: Studies of multiple sclerosis in Winnipeg, Manitoba, and New Orleans, Louisiana, Am. J. Hyg. 57: 380, 1953. MedlineGoogle Scholar7. Dean G: Disseminated sclerosis in South Africa; its relationship to swayback disease and suggested treatment, Brit. M. J. 1: 842, 1949. CrossrefMedlineGoogle Scholar8. The State of Food and Agriculture for 1948, United Nations Food and Agriculture Organization, Washington, D. C., 1948. Google Scholar9. Swank RL: Multiple sclerosis: a correlation of its incidence with dietary fat, Am. J. M. Sc. 220: 421, 1950. CrossrefMedlineGoogle Scholar10. SwankLerstadStrømBacker RLOAJ: Multiple sclerosis in rural Norway: its geographic and occupational incidence in relation to nutrition, New England J. Med. 246: 721, 1952. CrossrefGoogle Scholar11. Thygesen P: Analysis of the course of multiple sclerosis, Acta psychiat. et neurol., Supp. 74: 48, 1951. Google Scholar12. HopkinsSwank CERL: Multiple sclerosis and the local weather, Arch. Neurol. and Psychiat. 74: 203, 1955. CrossrefGoogle Scholar13. PutnamChiavacciHoffWeitzern IJLVHHG: Results of treatment of multiple sclerosis with dicumarin, Arch. Neurol. and Psychiat. 57: 1, 1947. CrossrefMedlineGoogle Scholar14. Macchi G: Pathology of the blood vessels in multiple sclerosis, J. Neuropath. and Exper. Neurol. 13: 378, 1954. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Portland, Oregon*Presented at the Thirty-seventh Annual Session of The American College of Physicians, Los Angeles, California, April 20, 1956.Supported by a grant from the Multiple Sclerosis Society of Portland, Oregon.From the Division of Neurology, University of Oregon Medical School, Portland, Oregon.Requests for reprints should be addressed to Roy L. Swank, M.D., Division of Neurology, University of Oregon Medical School, 3161 Southwest Sam Jackson Park Road, Portland 1, Oregon. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDietary Approaches to Treating Multiple Sclerosis-Related SymptomsFeasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosisDietary interventions for multiple sclerosis-related outcomesNutrient Composition Comparison between the Low Saturated Fat Swank Diet for Multiple Sclerosis and Healthy U.S.-Style Eating PatternReview of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified PaleolithicDietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trialA History of Multiple Sclerosis Investigations in Canada Between 1850 and 1950Fat-soluble vitamins as disease modulators in multiple sclerosisEfficacy of Fish Oil on Serum of TNF α , IL-1 β , and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1bOn the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple SclerosisMultiple SclerosisDietary interventions for multiple sclerosisPolyunsaturated fatty acids and their potential therapeutic role in multiple sclerosisDietary interventions for multiple sclerosisSome methodologic and sociodemographic issues in the epidemiology of multiple sclerosisThe social epidemiology of multiple sclerosisMultiple SclerosisDietary intake of linoleic acid in multiple sclerosis and other diseasesTreatment of Multiple Sclerosis with a Low-Fat Diet . Analysis of Nine and a Half Years' Experience 1 November 1956Volume 45, Issue 5Page: 812-824KeywordsChocolateDietFatsFoodIngestionMeatMilkMultiple sclerosisOilsProteins ePublished: 1 December 2008 Issue Published: 1 November 1956 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
R. L. Swank (1956) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: